Skip to main content
Oxford Biomedica PLC logo

Oxford Biomedica PLC — Investor Relations & Filings

Ticker · OXB ISIN · GB00BDFBVT43 LEI · 213800S1GVQNXQ15K851 IL Manufacturing
Filings indexed 915 across all filing types
Latest filing 2026-06-02 Regulatory Filings
Country GB United Kingdom
Listing IL OXB

About Oxford Biomedica PLC

https://www.oxb.com/

Oxford Biomedica (OXB) is a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. A pioneer in the field, the company has extensive experience in viral vectors, the enabling technology for many advanced therapies. OXB provides end-to-end services to pharmaceutical and biotechnology partners, supporting programs from preclinical development through to commercial launch. Its core expertise includes the development and GMP manufacturing of various vector types, including lentivirus, adeno-associated virus (AAV), and adenovirus. The company offers proprietary technologies like its LentiVector™ platform, the first commercially approved lentiviral system, and its inAAVate™ platform for AAV, in addition to tech-transfer capabilities.

Recent filings

Filing Released Lang Actions
OXB Capital Markets Event
Regulatory Filings Classification · 87% confidence The document is an RNS announcement detailing an upcoming Capital Markets Event (date, speakers, location, registration) rather than the actual investor presentation or financial report itself. It contains no substantive financial data, slide decks, or transcript, and serves as a regulatory/news release. Thus it falls under the general Regulatory Filings category (RNS).
2026-06-02 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is a short RNS announcement titled “Total Voting Rights,” stating the company’s issued share capital, number of ordinary shares and total voting rights as at a specific date, and referencing FCA Disclosure Guidance and Transparency Rule. This matches a voting rights announcement rather than a financial report or other filing. Hence it falls under Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-06-01 English
Director Declaration
Board/Management Information Classification · 97% confidence The document is a Regulatory News Service announcement from the London Stock Exchange about the appointment of an existing director (Peter Soelkner) to another board position. It is announcing a change related to the company’s board of directors (a director’s appointment), which fits the Board/Management Information category.
2026-05-27 English
Director/PDMR Shareholding
Director's Dealing Classification · 95% confidence The document is an RNS announcement detailing share transactions (option exercises and sales) by Persons Discharging Managerial Responsibilities (PDMRs). It reports insider dealings, including exact volumes, prices, and transaction types. This matches the “Director’s Dealing” category, which covers personal share transactions by company directors and executives under market abuse regulation.
2026-05-22 English
PDMR Dealing
Director's Dealing Classification · 95% confidence The document is an RNS announcement detailing an insider transaction by a Person Discharging Managerial Responsibilities (PDMR) – the exercise and disposal of share units by a senior executive. This clearly matches the definition of a Director’s Dealing report (insider share transactions).
2026-05-19 English
PDMR Dealing
Director's Dealing Classification · 95% confidence The document is an RNS announcement detailing personal share transactions by Persons Discharging Managerial Responsibilities (PDMRs) – officers exercising options and selling shares under EU Market Abuse Regulation. This exactly matches insider/director dealings. Therefore, it should be classified as Director's Dealing (DIRS).
2026-05-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.